Curis Inc. (CRIS)

NASDAQ

$0.39

$+0.00

(+1.15%)

Regular Market

Curis Inc. (CRIS) Live Price Chart

Last updated: ⁦2026-10-20 14:40:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Curis Inc. (CRIS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $0.39, with a market capitalization of $987.25K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.33 to $33.60. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$987.25K
Open	$0.37
Day's High	$13,180.00
Day's Low	$0.33
Previous Close	$0.38
Volume	44.67K
Average Volume	238.21K
P/E Ratio	--
52-Week High	$33.60
52-Week Low	$0.33
Dividend Yield	--
Earnings Date	--

Curis Inc. (CRIS) Stock Price Today

Curis Inc. (CRIS) is currently trading at $0.39 as of 2026-10-20 14:39:00, up 1.94% ($0.01) from the previous close of $0.38

During today's regular trading session, CRIS has traded between $0.33 and $13,180.00, with a trading volume of 44.67K shares. The current price is near the lower end of today's range.

Curis Inc. (CRIS) 7-Day Stock Price Change

Over the past seven days, Curis Inc. (CRIS) moved from $0.67 to $0.39, representing a decline of 42.04% ($0.28).

The stock traded between $0.33 and $0.72 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 378.64 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

CRIS 52-Week Price Position

Position in Range: 0.2%

52W Low$0.33

52W High$33.60

CRIS is currently trading at $0.39, placing it 0.2% of the way from its 52-week low of $0.33 to its 52-week high of $33.60. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Curis Inc. (CRIS)?

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Curis Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	24
Exchange	NASDAQ
Company Website	https://www.curis.com

How to Buy Curis Inc. (CRIS) Stock on MEXC

Eligible investors can buy real shares of Curis Inc. (CRIS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CRIS and Place Your Order

Open the RealStocks trading page and search for CRIS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Curis Inc. (CRIS) stock price today?

Curis Inc. (CRIS) is currently trading at $ 0.39, up 1.94% ($0.01) from the previous close of $ 0.38. Intraday prices update in real time during regular trading hours.

2.Is CRIS stock going up or down today?

As of 2026-10-20 14:39:00, CRIS is trading at $ 0.39, up 1.94% ($0.01) from its previous close of $ 0.38. The stock has traded between $ 0.33 and $ 13,180.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is CRIS pre-market price?

As of 2026-10-20 14:39:00, CRIS is trading at $ 0.36 in pre-market trading, down 5.14% ($0.02) from the previous close of $ 0.38. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CRIS after-hours price?

As of 2026-10-20 14:39:00, CRIS is trading at $ 0.41 in after-hours trading, up 6.13% ($0.02) from the regular-session close of $ 0.38. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CRIS stock trading now?

CRIS trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CRIS sit relative to its 52-week high and low?

Over the past 52 weeks, CRIS has traded between a low of $ 0.33 and a high of $ 33.60. At $ 0.39, the stock is positioned 0.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Curis Inc. in?

Curis Inc. (CRIS) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Curis Inc.'s market capitalization and where is it listed?

Curis Inc. is listed on the NASDAQ exchange with a market capitalization of $ 987.25K. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CRIS valued in terms of P/E ratio and EPS?

CRIS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -8.72. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Curis Inc. pay a dividend?

Curis Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.